CVN058 Effect on Mismatch Negativity in Schizophrenics
Clinical trial NCT03669250 · COMPLETED
Trial details
- NCT number
- NCT03669250
- Sponsor
- Cerevance Alpha, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-09
- Primary completion
- 2020-03-06
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.